AI-generated summary
The authors report a systematic review of 23 double-blind, sham-controlled randomized trials of noninvasive brain stimulation in neurodevelopmental disorders, including TMS, tDCS and transcranial photobiomodulation. They describe possible benefits for certain outcomes, such as irritability in autism with tPBM, alongside mild adverse effects and one seizure during TMS. The authors note high methodological variability, small samples and bias concerns, and call for further research.
- Studies included
- 23
- Who or what was studied
- Individuals with neurodevelopmental disorders, including attention-deficit hyperactivity disorder, autism spectrum disorder and dyslexia
- Limits stated in the abstract
- The abstract cites high methodological variability, sample size limitations and bias concerns across the included studies.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on psychiatryonline.org.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Systematic review, Transcranial magnetic stimulation, Attention-deficit/hyperactivity disorder, Transcranial direct current stimulation, Transcranial photobiomodulation, Photobiomodulation, Sample size, Autism. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.